ロード中...
Different infusion durations for preventing platinum‐induced hearing loss in children with cancer
BACKGROUND: Platinum‐based therapy, including cisplatin, carboplatin or oxaliplatin, or a combination of these, is used to treat a variety of paediatric malignancies. Unfortunately, one of the most important adverse effects is the occurrence of hearing loss or ototoxicity. In an effort to prevent th...
保存先:
| 出版年: | Cochrane Database Syst Rev |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Ltd
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6516894/ https://ncbi.nlm.nih.gov/pubmed/29975402 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD010885.pub4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|